PROVIDENCE – Brown University’s Technology Venture Office has reached an agreement with Lifespan to provide IP management and commercialization services to the health care system and has expanded its existing relationship with the Care New England hospital network, the university announced Monday.
In a release, Brown University and hospital officials said that the agreements were “bringing together in one place much of the licensable life science intellectual property developed by scientists across each institution.”
According to Brown, the two health care systems and Brown’s Division of Biology and Medicine earned $200.3 million worth of biomedical research funding during the 2012 fiscal year. The release added that other academic departments at Brown, including chemistry, also conduct “significant amounts” of life sciences-related research.
“At the university and the hospitals, such research produces discoveries and inventions every year,” said the release.
The Lifespan agreement calls for Brown to provide IP identification, reporting, protection, marketing, licensing and business development services for some of the new discoveries made by hospital-based scientists.
The Care New England deal, which was finalized in late 2012, expanded Brown’s arrangement from Care New England’s Women & Infants Hospital to include Butler Hospital and Kent Hospital.
“Providence’s collectively growing biomedical enterprise has a lot to offer the world, and Brown has the expert staff and relationships to help connect our state’s scientists with the opportunities their ingenuity creates,” Brown Provost Dr. Mark Schlissel, said in prepared remarks. “We are pleased to work with Lifespan and Care New England to bring new discoveries to the marketplace where they can help patients in need.”
Lifespan’s hospital network includes Rhode Island Hospital, Hasbro Children’s Hospital, The Miriam Hospital, Bradley Hospital and Newport Hospital.
“This terrific collaboration among the largest research institutions in the state will result in greater accomplishments for our scientists,” Dr. Peter Snyder, Lifespan senior vice president and chief research officer and professor of neurology in the Warren Alpert Medical School said in prepared remarks.
“Not only does this benefit our researchers, but it is a boon to our knowledge-based economy with the promise of more patents and commercial licenses coming out of Rhode Island,” added Snyder.